Skip to content
10-Q

Quarterly Report

BioPlus Acquisition Corp.

0001193125-22-217405

← back to feed
Filed
Aug 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Current Liabilities Q2 2022 · Jun 30, 2022 $241.53K
Current Liabilities Q2 2022 · Dec 31, 2021 $179.14K
Total Liabilities Q2 2022 · Jun 30, 2022 $15.04M
Total Liabilities Q2 2022 · Dec 31, 2021 $14.98M
Current Assets Q2 2022 · Jun 30, 2022 $715.54K
Current Assets Q2 2022 · Dec 31, 2021 $1M
Total Assets Q2 2022 · Jun 30, 2022 $235.81M
Total Assets Q2 2022 · Dec 31, 2021 $235.98M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$111
Stockholders Equity Q2 2022 · Jun 30, 2021 $18.86K
Stockholders Equity Q2 2022 · Mar 31, 2021 $20K
Stockholders Equity Q2 2022 · Feb 10, 2021 $0
Net Income Q2 2022 · Jun 30, 2021 −$1.14K
Net Income Q2 2022 · Jun 30, 2021 −$6.14K
Net Income Q2 2022 · Mar 31, 2021 −$5K
Operating Income Q2 2022 · Jun 30, 2021 −$1.14K
Operating Income Q2 2022 · Jun 30, 2021 −$6.14K